These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24891954)

  • 1. Melanoma Development and Progression Are Associated with Rad6 Upregulation and β -Catenin Relocation to the Cell Membrane.
    Rosner K; Mehregan DR; Kirou E; Abrams J; Kim S; Campbell M; Frieder J; Lawrence K; Haynes B; Shekhar MP
    J Skin Cancer; 2014; 2014():439205. PubMed ID: 24891954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rad6 is a Potential Early Marker of Melanoma Development.
    Rosner K; Adsule S; Haynes B; Kirou E; Kato I; Mehregan DR; Shekhar MP
    Transl Oncol; 2014 May; 7(3):384-92. PubMed ID: 24831578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
    Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
    BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
    de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
    Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin Expression and Activation in Conjunctival Melanoma.
    Larivé E; Nicolas M; Kaya G; Riggi N; Moulin AP
    Dermatopathology (Basel); 2019; 6(2):50-62. PubMed ID: 31700844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
    Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
    Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
    Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
    Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.
    Danen EH; Jansen KF; Van Kraats AA; Cornelissen IM; Ruiter DJ; Van Muijen GN
    Int J Cancer; 1995 May; 61(4):491-6. PubMed ID: 7538977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
    Flørenes VA; Maelandsmo GM; Holm R; Reich R; Lazarovici P; Davidson B
    Am J Clin Pathol; 2004 Sep; 122(3):412-20. PubMed ID: 15362372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
    Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
    Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.
    Jørgensen K; Holm R; Maelandsmo GM; Flørenes VA
    Clin Cancer Res; 2003 Nov; 9(14):5325-31. PubMed ID: 14614017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
    Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
    Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
    Omholt K; Platz A; Ringborg U; Hansson J
    Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
    Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of polycomb group protein EZH2 in nevi and melanoma.
    McHugh JB; Fullen DR; Ma L; Kleer CG; Su LD
    J Cutan Pathol; 2007 Aug; 34(8):597-600. PubMed ID: 17640228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.